These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 19198637)

  • 1. Effect of lactoferricin on fluoroquinolone susceptibility of uropathogenic Escherichia coli.
    Longhi C; Marazzato M; Conte MP; Iebba V; Schippa S; Seganti L; Comanducci A
    J Antibiot (Tokyo); 2009 Feb; 62(2):109-11. PubMed ID: 19198637
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid and sensitive detection of fluoroquinolone-resistant Escherichia coli from urine samples using a genotyping DNA microarray.
    Yu X; Susa M; Weile J; Knabbe C; Schmid RD; Bachmann TT
    Int J Med Microbiol; 2007 Oct; 297(6):417-29. PubMed ID: 17482874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of fluoroquinolone resistance in Escherichia coli isolates at the department of clinical hematology.
    Zemkova M; Kotlarova J; Merka V; Cermak P; Vlcek J; Jebavy L
    New Microbiol; 2007 Oct; 30(4):423-30. PubMed ID: 18080678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of fluoroquinolone-resistant Escherichia coli in urinary tract infections.
    Shigemura K; Arakawa S; Miura T; Nakano Y; Tanaka K; Fujisawa M
    Jpn J Infect Dis; 2008 May; 61(3):226-8. PubMed ID: 18503177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
    Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
    Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
    J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.
    Gagliotti C; Buttazzi R; Sforza S; Moro ML;
    J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
    Yamane K; Wachino J; Suzuki S; Kimura K; Shibata N; Kato H; Shibayama K; Konda T; Arakawa Y
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3354-60. PubMed ID: 17548499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissemination of clonal groups of uropathogenic Escherichia coli is not a significant contributor to trimethoprim and sulfamethoxazole resistance in Galway, Ireland.
    Morris D; Ni Chulain M; Cormican M
    Int J Antimicrob Agents; 2007 Jul; 30(1):97-8. PubMed ID: 17459666
    [No Abstract]   [Full Text] [Related]  

  • 10. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
    Caron F; Etienne M
    Am J Med; 2010 Mar; 123(3):e13. PubMed ID: 20193811
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005).
    Nys S; Terporten PH; Hoogkamp-Korstanje JA; Stobberingh EE;
    J Antimicrob Chemother; 2008 Jul; 62(1):126-32. PubMed ID: 18417487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone-resistant Escherichia coli: food for thought.
    Collignon P; Angulo FJ
    J Infect Dis; 2006 Jul; 194(1):8-10. PubMed ID: 16741876
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between susceptibility to antimicrobials and virulence factors in paediatric Escherichia coli isolates.
    Arisoy M; Rad AY; Akin A; Akar N
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S4-8. PubMed ID: 17959360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolone resistance in Escherichia coli and Klebsiella pneumoniae over 18 years: effect of different systems for eliminating duplicates.
    Noguera O; López-Riquelme N; Rodríguez JC; Belda S; Galiana A; Ruiz-García M; López-García P; Royo G
    J Antimicrob Chemother; 2011 Sep; 66(9):2182-4. PubMed ID: 21693462
    [No Abstract]   [Full Text] [Related]  

  • 15. [Occurrence of enteropathogenic serotypes of Escherichia coli in urinary tract infections].
    Schmid E; Sonnabend W
    Pathol Microbiol (Basel); 1973; 39(5):348-57. PubMed ID: 4580715
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
    Gualco L; Schito AM; Schito GC; Marchese A
    Int J Antimicrob Agents; 2007 Jun; 29(6):679-87. PubMed ID: 17363225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility testing of Escherichia coli isolates from urines: are we at risk of reporting false antibiotic resistance to co-amoxiclav?
    Bond A; Plumb H; Turner P
    J Antimicrob Chemother; 2012 Jun; 67(6):1557-8. PubMed ID: 22334608
    [No Abstract]   [Full Text] [Related]  

  • 18. Rise in ciprofloxacin resistance in Escherichia coli from urinary tract infections from 1999-2004.
    Barisić Z; Borzić E; Kraljević KS; Carev M; Zoranić V; Kaliterna V
    Int J Antimicrob Agents; 2005 Jun; 25(6):550-1. PubMed ID: 15878822
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic relatedness between human and animal polymorphic blaTEM genes strengthens zoonotic potential among uropathogenic Escherichia coli strains.
    Caniça M; Dias R; Correia JD; Pomba C
    J Antimicrob Chemother; 2004 Jul; 54(1):284-6. PubMed ID: 15190024
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between fluoroquinolone resistance and resistance to other antimicrobial agents among Escherichia coli urinary isolates in the outpatient setting: a national cross-sectional study.
    Hwang TJ; Hooper DC
    J Antimicrob Chemother; 2014 Jun; 69(6):1720-2. PubMed ID: 24521853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.